Stay updated on Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    A new site revision label, v3.3.4, was added and the previous revision, v3.3.3, was removed. This represents a routine background update with no changes to trial data or user-facing functionality.
    Difference
    0.0%
    Check dated 2026-01-14T02:43:43.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page now includes a new entry: Revision: v3.3.3. The footer link 'HHS Vulnerability Disclosure' and the older 'Revision: v3.3.2' have been removed.
    Difference
    0.1%
    Check dated 2025-12-23T13:33:17.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    Record History shows a new metadata revision (Revision: v3.3.2) added and an older revision (Revision: v3.2.0) removed; this reflects version metadata rather than content changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T18:27:39.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    - Removed a prominent notice stating that information on the site may not be up to date due to government funding lapses and that the NIH Clinical Center is open, with links to cc.nih.gov and opm.gov for status updates.
    Difference
    0.3%
    Check dated 2025-11-17T18:02:50.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The Record History for NCT03631199 now shows additional history entries, reflecting newer submissions and status updates.
    Difference
    0.0%
    Check dated 2025-11-03T12:34:16.000Z thumbnail image
  8. Check
    110 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to operating status information, signaling potential delays in processing and inquiries. - Updated version to v3.2.0 and removed the previous v3.1.0 reference.
    Difference
    7%
    Check dated 2025-10-05T16:44:54.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial page.